Epidermal growth factor receptor-targeted near-infrared probe cetuximab-IRDye800CW enables stable and tumor-specific fluorescence imaging in colorectal cancer models
Cetuximab-IRDye800CW provides stable, tumor-specific, high-contrast fluorescence imaging in EGFR-high CRC models. These findings validate its molecular targeting capability and support its translational potential for fluorescence-guided CRC surgery.
Authors
- Yong Huang (ORCID: https://orcid.org/0000-0001-8897-5651)
- Xianhu Zhang (ORCID: https://orcid.org/0000-0001-5593-6322)
- Yongjun Jiang
- Daorong Wang (ORCID: https://orcid.org/0000-0003-1245-4002)
Institutions
- Northern Jiangsu People's Hospital (CN)
Publication Details
- Journal
- Journal of Biomedical Optics
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1117/1.jbo.30.12.126002
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00